Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

343 results about "Enteritis" patented technology

Enteritis is inflammation of the small intestine. It is most commonly caused by food or drink contaminated with pathogenic microbes, such as serratia, but may have other causes such as NSAIDs, cocaine, radiation therapy as well as autoimmune conditions like Crohn's disease and coeliac disease. Symptoms include abdominal pain, cramping, diarrhoea, dehydration, and fever.

Lactobacillus reuteri HNU872 and application thereof in preparation of intestinal inflammation related products

The invention provides lactobacillus reuteri HNU872 and application of the lactobacillus reuteri HNU872 in preparation of intestinal inflammation related products. The invention discloses how the Lactobacillus reuteri HNU872 effectively alleviates the phenotype of DSS-induced mouse enteritis. The invention also discloses a preparation method of the Lactobacillus reuteri HNU872. Research results show that the Lactobacillus reuteri HNU872 can significantly relieve weight loss caused by enteritis, improve colon length, significantly improve the level of anti-inflammatory cytokines in serum and reduce the concentration of pro-inflammatory cytokines. In addition, the expression of the intestinal tight junction protein ZO-1 is obviously promoted. The lactobacillus reuteri HNU872 can regulate diversity and structure of intestinal microbiota of mice, inhibit enrichment of pathogenic bacteria and relieve inflammatory response. According to the invention, the action mechanism of the lactobacillus reuteri HNU872 in improving enteritis is clarified, and a solid scientific basis is provided for developing a microbial product based on probiotics as an alternative treatment strategy for ulcerative colitis.
Owner:HAINAN UNIV

Phytobacterium plantarum and application thereof in improving intestinal inflammation and repairing intestinal mucosa injury

The invention relates to the technical field of functional microorganism screening and application, and particularly provides a strain of lactobacillus plantarum and an application of the lactobacillus plantarum in improvement of intestinal inflammation and repair of intestinal mucosa injury. The plant lactobacillus is preserved in the China General Microbiological Culture Collection Center (CGMCC for short) on August 1, 2024, the address is No.3, No.1 Yard, Beichen West Road, Chaoyang District, Beijing, and the preservation number of the plant lactobacillus is CGMCC No.31521. The strain has remarkable antioxidant, bacteriostatic and anti-inflammatory effects, can repair intestinal barrier injury of mice with colitis, promote renewal of intestinal stem cells, promote growth of intestinal beneficial bacteria and inhibit proliferation of harmful bacteria, can be widely applied to prevention and treatment of enteritis, and has a wide market prospect.
Owner:SHENYANG AGRI UNIV

Lactobacillus plantarum capable of relieving enteritis and toxicity of polystyrene nano plastic and application of lactobacillus plantarum

The invention discloses lactobacillus plantarum capable of relieving enteritis and toxicity of polystyrene nano-plastics, and the preservation number of the lactobacillus plantarum is CGMCC (China General Microbiological Culture Collection Center) NO.31420. The lactobacillus plantarum can be used for relieving enteritis and toxicity of polystyrene nano-plastics. The strain is obtained by separating and purifying baby feces, and can grow on an MRS culture medium, and the bacterial colony is round, off-white, smooth and opaque. Experiments show that the lactobacillus plantarum can effectively adsorb PS-NPs, promote the PS-NPs to be discharged along with excrement, reduce accumulation of the PS-NPs in organs, and significantly reduce toxicity and inflammatory response of organs such as liver and kidney of mice. In addition, the strain can repair the intestinal barrier function, regulate liver metabolism and relieve enteritis symptoms. The invention further provides a probiotic preparation containing the strain, and the probiotic preparation can be prepared into granules, capsules, tablets or oral liquid and the like and is used for preventing or treating intestinal injury and inflammatory diseases caused by PS-NPs. The strain is safe and efficient, and has a wide application prospect.
Owner:HENAN NORMAL UNIV +1

Lactococcus gasseri ZB15, cell-free fermentation freeze-dried substance with anti-inflammatory activity and preparation method of cell-free fermentation freeze-dried substance

The invention relates to the technical field of fermentation, in particular to a strain of lactococcus gasseri ZB15, an acellular fermentation freeze-dried substance with anti-inflammatory activity and a preparation method of the acellular fermentation freeze-dried substance. The Lactococcus garvieae ZB15 is preserved in the Guangdong Microbial Culture Collection Center, the address is the 5th floor of building 59, No.100 Courtyard, Xianlie Middle Road, Guangzhou, Institute of Microbiology, Guangdong Academy of Sciences, the preservation date is February 27, 2025, and the preservation number is GDMCC No: 65947. The lactococcus gasseri ZB15 disclosed by the invention is prepared into an acellular fermentation freeze-dried substance, and the acellular fermentation freeze-dried substance can improve the body immunity by changing the intestinal microflora structure while relieving and improving enteritis, so that a basis is provided for the preparation of enteritis medicines.
Owner:SHAANXI SCI TECH UNIV

Fish feed containing traditional Chinese medicine components for preventing fish enteritis and preparation method of fish feed

The invention discloses a fish feed containing traditional Chinese medicine components for preventing fish enteritis and a preparation method thereof, and belongs to the technical field of fish enteritis prevention. Comprising the following raw materials in parts by weight: 5-8 parts of lactobacillus rhamnosus with the viable count of 1.2 * 10 < 5 >-1.5 * 10 < 5 > CFU / g per gram, 1-2 parts of symbiotic bacillus siamensis LF41 with the viable count of 1.1 * 10 < 5 >-1.2 * 10 < 5 > CFU / g per gram, 30-35 parts of rhein hydrogel and 16-28 parts of a traditional Chinese medicine extract composition, and the traditional Chinese medicine extract comprises the following medicinal materials in parts by weight: 6-10 parts of apple peel polyphenol, 2-5 parts of common wormwood, 3-5 parts of codonopsis pilosula and 5-8 parts of golden cypress. The traditional Chinese medicine extract is coated with the rhein hydrogel. The fish feed containing the traditional Chinese medicine components for preventing the fish enteritis prevents the fish enteritis through a TLR / NF kappa B signal channel, plays a role in targeting intestinal tracts after being eaten by fishes, and is good in drug effect.
Owner:HUIZHOU RENHE AGRICULTURAL TECHNOLOGY CO LTD

Water-soluble cassia twig volatile oil solution for laying fowls as well as preparation method and application thereof

The invention belongs to the technical field of veterinary drugs, discloses a water-soluble cassia twig volatile oil solution for laying fowls as well as a preparation method and application of the water-soluble cassia twig volatile oil solution, and particularly discloses the water-soluble cassia twig volatile oil solution which comprises the following components: cassia twig volatile oil, a preservative, an emulsifier, a co-emulsifier and an antioxidant. The water-soluble cassia twig volatile oil solution disclosed by the invention has a relatively strong in-vitro antibacterial effect, can effectively prevent and treat enteritis and salpingitis of laying fowls, improve the clinical dilute fecal symptom, reduce sand-shell eggs, soft-shell eggs and the like caused by salpingitis, improve the rate of certified eggs and prolong the egg laying peak.
Owner:GUANGDONG HAID GROUP

Synbiotic composition with bacteriostatic and anti-inflammatory effects and preparation method thereof

The invention discloses a synbiotics composition with bacteriostatic and anti-inflammatory effects, which comprises probiotics and prebiotics in parts by weight, the probiotics comprise the following components in parts by weight: 0.05 to 0.15 part of freeze-dried powder of lactobacillus rhamnosus PB-LR76, 0.05 to 0.15 part of freeze-dried powder of lactobacillus acidophilus HH-LA26, 0.05 to 0.15 part of freeze-dried powder of lactobacillus bulgaricus HH-LB57, 0.05 to 0.15 part of freeze-dried powder of bifidobacterium lactis HH-BA68, 0.05 to 0.15 part of freeze-dried powder of lactobacillus reuteri PB-LR09, and 0.05 to 0.15 part of freeze-dried powder of lactobacillus plantarum HH-LP56; the prebiotics are fructo-oligosaccharide or a rhizoma polygonati extract. Compared with the single use of probiotics or prebiotics, the synbiotics composition disclosed by the invention has stronger antibacterial and anti-inflammatory effects. The invention further discloses application of the synbiotics composition in preparation of a medicine for treating enteritis.
Owner:TAIAN CENT HOSPITAL (TAIAN CENT HOSPITAL AFFILIATED TO QINGDAO UNIV TAISHAN MEDICAL NURSING CENT)

Cobalt monatomic nano-enzyme ternary composite system as well as preparation method and application thereof

The invention provides a cobalt monatomic nano-enzyme system modified by phospholipid polyethylene glycol carboxyl. The cobalt monatomic nano-enzyme system comprises a cobalt monatomic nano-enzyme composite core and phospholipid polyethylene glycol carboxyl compounded on the surface of cobalt monatomic nano-enzyme, the cobalt monatomic nano-enzyme composite core comprises a cobalt monatomic nano-enzyme and ginsenoside loaded on the cobalt monatomic nano-enzyme. The invention also provides a bifidobacterium synergetic cobalt monatomic nano-enzyme system which is formed by combining cobalt monatomic nano-enzyme with ginsenoside Rb1 and further delivering the cobalt monatomic nano-enzyme and ginsenoside Rb1 through bifidobacterium bifidum for targeted therapy of enteritis. The combination of Co SA and Rb1 can enhance the anti-inflammatory efficacy by adjusting a key immune signal pathway, and bifidobacterium bifidum can ensure targeted delivery of microbiota and promote intestinal barrier repair. The synergistic three-component strategy integrating monatomic nano-enzyme antioxidation, natural drug immunoregulation and probiotic targeting is provided, and a promising treatment platform is provided for accurate intervention of IBD.
Owner:CHANGCHUN UNIV OF CHINESE MEDICINE

Application of Aldometanib in preparation of medicine for preventing and treating immune-related adverse reactions and diseases

The invention provides an application of a compound Aldometanib in preparation of a medicine for preventing and treating immune-related adverse reactions and diseases. Based on the first discovered prevention and treatment effects of Aldometanib on fatal immune hepatitis, immune myocarditis, pneumonia and enteritis, the invention specifically discloses application of Aldometanib in preparation of drugs for prevention and treatment of immune-related adverse reactions and diseases, and the main mechanism is that Aldometanib activates immune cells AMPK, enhances catabolism of immune cells, promotes immune cell apoptosis, promotes immune cell apoptosis, and improves immune cell apoptosis. The anabolism of the immune cells is inhibited, so that the expression of effector factors of the immune cells is controlled, and inflammatory factor storm is inhibited. Aldometanib has the effects of preventing the occurrence of immune-related adverse reactions and diseases, and inhibiting the attack levels of the immune-related adverse reactions and diseases, so that non-lethal and lethal injuries caused by an immune system to body organs are reduced.
Owner:FUJIAN CANCER HOSPITAL (FUJIAN CANCER INST FUJIAN CANCER PREVENTION & CONTROL CENT)

Construction method of anti-oxidation adhesion type genetically engineered bacterium, engineered bacterium and application of engineered bacterium

The invention discloses a construction method of an anti-oxidation adhesion type genetically engineered bacterium, the engineering bacterium and application of the engineering bacterium, and relates to the technical field of construction of the anti-oxidation adhesion type genetically engineered bacterium. According to the invention, superoxide dismutase and catalase are subjected to constitutive overexpression in a probiotic chassis by using a synthetic biological technology, and meanwhile, intestinal trefoil factor peptide fused pilin is subjected to overexpression. According to the present invention, the research results show that the active oxygen scavenging ability of the anti-oxidation adhesion type gene engineering probiotic is significantly improved, the adhesion ability of the anti-oxidation adhesion type gene engineering probiotic in the animal intestinal tract is significantly enhanced, and the radiation enteritis symptom caused by the whole abdomen ionizing radiation irradiation can be effectively relieved; the strain can be used as a potential safe viable bacterium medicine for preventing and treating radiation enteritis and other active oxygen related enteritis. The anti-oxidation adhesion type genetic engineering probiotics can be prepared into viable bacteria preparations such as viable bacteria suspension, dairy products, viable bacteria powder, bacterial tablets or capsules, can be proliferated and colonized in human intestinal tracts after being orally taken, and is applied to prevention and treatment of radiation enteritis.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Lactobacillus rhamnosus capable of preventing or treating inflammatory bowel disease and promoting digestion and application thereof

The invention relates to the technical field of microorganisms, in particular to lactobacillus rhamnosus capable of preventing or treating inflammatory bowel diseases and promoting digestion and application of the lactobacillus rhamnosus, and belongs to the technical field of biological medicine. The invention provides a strain of lactobacillus rhamnosus R7970, wherein the preservation number of the lactobacillus rhamnosus R7970 is CGMCC (China General Microbiological Culture Collection Center) 22244, and the preservation number of the lactobacillus rhamnosus R7970 is CGMCC 22244. The lactobacillus rhamnosus R7970 can be used for effectively preventing inflammatory enteritis (IBD) and has a prevention effect on intestinal inflammation, and meanwhile, the lactobacillus rhamnosus R7970 can be used for improving the nutrition digestion and absorption functions of intestinal tracts. Therefore, the lactobacillus rhamnosus R7970 can be applied to prevention of IBD, can be used for preparing probiotic preparations, common foods, health foods and biological pharmacy for improving intestinal health, is convenient for industrial production, and has great popularization value.
Owner:内蒙古科拓生物有限公司 +1

Engineering probiotics with surface modified protective shell, preparation method and application thereof

The invention relates to the technical field of biomedical engineering, in particular to engineered probiotics with a surface-modified protective shell, a preparation method and application of the engineered probiotics, the engineered probiotics with the surface-modified protective shell comprise the protective shell and engineered probiotics, and the engineered probiotics are coated with the protective shell; the engineered probiotics are subjected to surface modification through immune regulation factors, and metal ions are loaded on the surfaces of the engineered probiotics subjected to surface modification; the engineered probiotics with the surface modified protective shell can regulate immune factors, can be targeted and colonized in colon and promote repair of mucosa surface, and has a better treatment effect on enteritis, so that the engineered probiotics are expected to be applied to preparation of enteritis pharmaceutical preparations; according to the preparation method of the engineering probiotics, raw materials are easy to obtain, the operation process is simple and convenient, reaction conditions are controllable, and large-scale production is facilitated.
Owner:INST OF BIOMEDICAL ENG CHINESE ACAD OF MEDICAL SCI

Application of lotus leaf crude polysaccharide in prevention and treatment of ulcerative enteritis and salpingitis

The invention belongs to the technical field of natural product extraction and medicine, and particularly relates to application of lotus leaf crude polysaccharide in prevention and treatment of ulcerative enteritis and salpingitis. Lotus leaves are used as a raw material, a water extraction and alcohol precipitation method is adopted to obtain the lotus leaf crude polysaccharide, and in-vitro experiments prove that the lotus leaf crude polysaccharide is a polysaccharide with antioxidant and anti-inflammatory effects and is an ideal polysaccharide for preventing and treating ulcerative enteritis. In a DSS-induced ulcerative enteritis mouse model, by giving the lotus leaf crude polysaccharide, the mouse colitis symptom can be effectively relieved, the barrier function of colon is recovered, the inflammatory factor level is reduced, and the intestinal flora balance of the mouse is regulated. In a laying hen salpingitis model induced by mixed bacterial infection, the inflammation symptom of the salpingitis laying hen salpingitis can be effectively relieved by giving the lotus leaf crude polysaccharide, the physiological function of the salpingitis laying hen is recovered, and the laying rate is increased. Meanwhile, according to the technical scheme, the extraction and preparation method is simple, industrial implementation is facilitated, and therefore good economic and social benefits can be obtained.
Owner:YUNNAN AGRICULTURAL UNIVERSITY

Medicine for treating or preventing chicken coccidiosis and chicken necrotic enteritis and application

PendingCN119792362AAntibacterial agentsDigestive systemCoccidiosisDisease
The invention belongs to the technical field of medicine, and particularly relates to a medicine for treating or preventing chicken coccidiosis and chicken necrotic enteritis and application, the medicine is chaulmoogratree seed, and can be in the form of medicinal material powder or chaulmoogratree seed extract. The traditional Chinese medicine composition can be used for preventing and treating chicken coccidiosis diseases, reducing the death rate of broilers with necrotic enteritis and intestinal lesions of necrotic enteritis, effectively improving chicken necrotic enteritis and has a good popularization and application prospect in the aspect of preventing and treating chicken necrotic enteritis diseases; the traditional Chinese medicine composition has a good treatment effect on mixed infection diseases of small intestine coccidiosis and clostridium.
Owner:BEIJING CENT BIOLOGY CO LTD +1

Preparation method and application of fig extracellular exosome vesicles

The invention provides a preparation method and application of fig extracellular exosome vesicles, in the method, fig juice is treated by a differential-ultracentrifugation method, the fig juice is centrifuged for 20 min according to 2000 * g, and a supernatant A is collected; centrifuging the supernate A for 20 minutes according to 3000 * g, and collecting supernate B; centrifuging the supernate B for 60 minutes according to 10000 * g, and collecting supernate C; filtering the supernate C to obtain filtrate; the filtrate is subjected to ultracentrifugation for 90-120 min according to the standard of 100000-120000 * g, and precipitates are collected; re-suspending the precipitate by using a filtered and sterilized PBS solution to obtain extracellular exosome vesicles; the fig extracellular exosome vesicle is a natural product and can be used as a medicinal raw material; the medicinal raw material can be applied to preparation of medicines for treating inflammatory enteritis, and has good biocompatibility.
Owner:DEZHOU UNIV

Lactococcus lactis Jlus 880314 and application thereof

The invention belongs to the field of microorganisms, and particularly relates to lactococcus lactis Jlus 880314 and application thereof. The strain is classified and named as Lactococcus lactis, and is preserved in the China General Microbiological Culture Collection Center (CGMCC), and the preservation address is No.3, Yard 1, Beichen West Road, Chaoyang District, Beijing; the preservation number of the strain is CGMCC No. 33961. Time-of-flight mass spectrometry analysis shows that nisin exists in a metabolite of the strain, and the strain can be used for producing nisin. The compound shows an excellent and wide antibacterial function in antibacterial experiments, can be used for preparing antibacterial drugs, particularly has a remarkable inhibiting effect on growth of gram-negative bacteria and fungi, can be used for preparing drugs for relieving or treating enteritis, or preparing drugs, nourishment or health care products for regulating gastrointestinal tract micro-ecological balance of people or animals, and can be used for preparing medicines for relieving or treating enteritis. The compound can also be used for preparing antibacterial food additives and / or animal feed additives. A hemolysis experiment result shows that hemolysis is avoided, toxic and side effects are small, and wide development prospects and application values are achieved.
Owner:JILIN UNIVERSITY +1

Composite probiotic inulin gel biomass preparation as well as preparation method and application thereof

The invention discloses a composite probiotic inulin gel biomass preparation as well as a preparation method and application thereof. Relates to the technical field of food. The raw materials comprise composite probiotics and inulin gel. The invention further provides a preparation method and application. The oral compound probiotic inulin gel preparation provided by the invention is good in safety, and is used for preventing ionizing radiation hematopoietic system injury and radiation enteritis; wherein the inulin gel has a certain protection effect on gastric acid and intestinal juice, and probiotics are protected from being damaged. The inulin gel can prolong the retention of the probiotics in the intestinal tract and enhance the colonization effect of the probiotics in the intestinal tract. The compound probiotics have a certain synergistic effect.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Preparation method and application of silk fibroin-based hydrogel

The invention discloses a preparation method and application of silk fibroin-based hydrogel, and the preparation method of the silk fibroin-based hydrogel comprises the following steps: step 1, extracting a silk fibroin solution by using silkworm cocoon as a raw material; 2, a preset amount of cross-linking agent is added into the silk fibroin solution, stirring reaction is conducted, then an excessive dopamine and aminomannose mixed solution is added, silk fibroin-based hydrogel is obtained, the molar ratio of the added dopamine to the aminomannose is 1: (0.5-2), probiotics are placed into the silk fibroin-based hydrogel through a micro-fluidic chip, and the hydrogel is prepared through the steps of preparing the silk fibroin-based hydrogel through the micro-fluidic chip. The probiotic microcapsules are obtained. The invention aims to realize that the probiotic microcapsule is used for treating intestinal inflammation, not only can be used for treating enteritis, but also can be used for encapsulating the probiotics from being damaged by gastric acid and gastrointestinal digestive enzyme, and meanwhile, the growth and reproduction of the probiotics are not influenced.
Owner:HUNAN AGRI UNIV

Phytobacterium plantarum and probiotic composition thereof, and application thereof in relieving dog stress and improving dog enteritis

The invention discloses a plant lactobacillus Kimate-F, a plant lactobacillus Kimate-6, a composite probiotic composition composed of the plant lactobacillus Kimate-F and the plant lactobacillus Kimate-6, and an application of the composite probiotic composition in relieving dog transportation stress and improving dog enteritis. The probiotic composition can effectively relieve dog transportation stress and remarkably reduce indexes such as corticosterone and active oxygen. In addition, the probiotic composition can effectively prevent or relieve canine enteritis, promote reproduction of beneficial bacteria in intestinal flora, inhibit proliferation of potential harmful bacteria, repair intestinal mucosal barrier and reduce inflammatory response. The invention has a wide application prospect, is especially suitable for dogs with long-distance transportation, stress susceptibility and poor intestinal function, and can also be used in cooperation with other conventional treatment means.
Owner:DIPROBIO (SHANGHAI) CO LTD

CuS / PGS-PSBMA-calcium alginate hydrogel microsphere for treating inflammatory bowel disease and preparation method of CuS / PGS-PSBMA-calcium alginate hydrogel microsphere

The invention discloses a CuS / PGS-PSBMA-calcium alginate hydrogel microsphere for treating inflammatory bowel disease and a preparation method thereof, and the preparation method of the oral hydrogel microsphere comprises the following steps: (1) crosslinking CuS / PGS and PSBMA, and preparing the CuS / PGS-PSBMA hydrogel microsphere by adopting an air flow control technology; and (2) performing calcium ion diffusion cross-linking to obtain a core-shell structure hydrogel microsphere with calcium alginate as a shell and CuS / PGS-PSBMA as a core, thereby obtaining the CuS / PGS-PSBMA-calcium alginate hydrogel microsphere for treating the inflammatory bowel disease. The core-shell structure hydrogel microsphere for treating the inflammatory bowel disease is prepared by utilizing an air flow control technology and an ion diffusion method, can be accurately dissolved and release hydrogel at the colon part after being orally taken, and is adhered to the local intestinal wall to promote polarization of intestinal M2 macrophages, so that the inflammatory bowel disease is treated, and the curative effect is good. The medicine is a safe and multi-effect enteritis treatment medicine with clinical transformation significance.
Owner:WENZHOU MEDICAL UNIV

High-temperature-resistant and inflammation-relieving Witzia ciliaris CN985 and application thereof

The invention provides a strain of high-temperature-resistant and inflammation-relieving Witzia ciliaris and an application thereof, the high-temperature-resistant and inflammation-relieving Witzia ciliaris is Witzia ciliaris CN985 and is preserved in the China Center for Type Culture Collection (CCTCC), the preservation date is April 7, 2024, and the preservation number is CCTCC NO: M 2024641. The invention further provides a preparation method of the high-temperature-resistant and inflammation-relieving Witzia ciliaris strain for preventing and treating inflammation of the high-temperature-resistant and inflammation-relieving Witzia ciliaris strain for preventing and treating inflammation of the high-temperature-resistant and inflammation-relieving Witzia ciliaris strain. The invention provides a brand new strain of Witzia ciliaris CN985, which is resistant to high temperature, has better acid resistance and bile resistance, and has no hemolysis risk when being applied to a human body. The Witzia coagulans CN985 has excellent antibacterial performance, and especially can significantly inhibit streptococcus pyogenes, salmonella enteritidis and / or group B streptococcus; besides, experimental results show that the Witzia ciliaris CN985 can relieve enteritis, improve the immunity of the organism and relieve pharyngitis, and especially when the Witzia ciliaris CN985 and the phytobacterium plantarum CE18 are combined for use, the Witzia ciliaris CN985 and the phytobacterium plantarum CE18 have a synergistic interaction effect, so that the relieving effect on enteritis can be remarkably improved.
Owner:KEWEI BIOLOGICAL (ZHENJIANG) CO LTD

Genetically modified microorganisms and their uses

The present disclosure provides a genetically modified microorganism and its use. The genetically modified microorganism expresses at least one, two or three exogenous genes (Amuc_1100 polypeptide, IL-10 and / or IL-22). The genetically modified microorganism of the present disclosure can stably survive after the introduction of the exogenous genes of interest, and can efficiently express and secrete the proteins or polypeptides encoded by these exogenous genes in the intestine, and the proteins or polypeptides encoded by the expressed and secreted exogenous genes can still maintain good activity, and thus can be used to treat inflammatory diseases or autoimmune diseases (e.g., enteritis, arthritis).
Owner:コムバイオ セラピューティクス カンパニーリミテッド

Feed additive for preventing broiler necrotic enteritis, preparation method and application

The invention discloses a feed additive for preventing broiler necrotic enteritis, a preparation method and application, and relates to the technical field of feed. Comprising the following raw materials in parts by weight: 15-30 parts of plant essential oil, 40-60 parts of deoxycholic acid, 10-20 parts of vitamin D310, 3-8 parts of protein zinc, 2-6 parts of saccharomyces cerevisiae and 1-5 parts of zeolite powder. The feed additive provided by the invention is clear in component, stable in property, convenient to operate and control, easy to realize industrial production, and convenient to popularize and apply. By adopting the feed additive provided by the invention, the integrity of the intestinal epithelial barrier can be improved, the intestinal flora structure can be improved, the immunity of the organism can be improved, and necrotic enteritis of broilers can be effectively prevented.
Owner:INST OF ANIMAL SCI & VETERINARY HUBEI ACADEMY OF AGRI SCI

Diagnostic support method for enteritis based on biogas analysis

To provide a diagnostic support method for enteritis in a simple and non-invasive manner.SOLUTION: Provided is a diagnostic support method for enteritis in a subject, comprising: measuring the concentration of hydrogen in a gas mixture discharged from the subject; and comparing the measured value or the standard deviation of the measured value with a reference value.SELECTED DRAWING: Figure 4
Owner:KEIO UNIV +1

Aleppo avens n-acetone extract and application thereof in treating necrotic enteritis

The invention relates to an aleppo avens n-acetone extract and application thereof in treating necrotic enteritis. The aleppo avens n-acetone extract is obtained through a reflux extraction method, and the extraction conditions are as follows: the acetone concentration is 50% or 75%, the reaction time is 0.5 h or 1 h, the material-liquid ratio is 1: 5 or 1: 10, and the extraction temperature is 65 DEG C. According to the invention, a reflux extraction method is adopted to extract the aleppo avens, and the obtained aleppo avens n-acetone extract contains various compounds such as ellagic acid, buddleoside, 4, 4 '-dimethyl ellagic acid and the like; the aleppo avens n-acetone extract can increase the villus height of duodenum and jejunum and the ratio of villus height to crypt depth, maintain the morphological structure in the duodenum intestinal tract, increase the content of acetic acid, propionic acid and butyric acid in cecum, and significantly reduce necrotic enteritis lesion.
Owner:INST OF ANIMAL HEALTH GUANGDONG ACADEMY OF AGRI SCI

Anomycobacterium and application thereof in enteritis treatment

The present invention provides a strain of the genus Alistipes as well as a pharmaceutical composition comprising the strain or an extract of the strain. The strain and the pharmaceutical composition disclosed by the invention can be used for remarkably relieving such symptoms as weight loss, shortened colon length, inflammatory factor release and the like of an enteritis object, and do not have toxic or side effects. Therefore, the another mycobacterium strain or the active extract of the another mycobacterium strain can be used for preparing pharmaceutical compositions and fermented foods for relieving enteritis, and has a very wide application prospect.
Owner:IBIOME BIOTECHNOLOGY CO LTD

Magnesium boride nanosheet / inulin composite hydrogel and application of magnesium boride nanosheet / inulin composite hydrogel in treatment of inflammatory bowel disease and concurrent mental diseases

The invention discloses a magnesium boride nanosheet / inulin composite hydrogel and application thereof in treating inflammatory bowel diseases and complicated mental diseases, and the composite hydrogel is synthesized by doping magnesium boride nanosheets into inulin and carrying out hot melting and cooling to form gel. The composite hydrogel has good oxidation resistance and biocompatibility, reducing hydrogen can be generated through a hydrolysis reaction to be used for reducing active oxygen and inflammatory factors of the enteritis part, intestinal flora can be adjusted, meanwhile, the composite hydrogel can be prevented from being affected by gastric acid and reach the intestinal part through the addition of inulin, and the enteritis treatment effect is improved. Therefore, the inflammatory bowel disease and related anxiety and depression symptoms thereof are effectively treated.
Owner:HEFEI UNIV OF TECH

Phagocytosis-resistant indigo engineering bacteria as well as preparation method and application of phagocytosis-resistant indigo engineering bacteria

PendingCN119823926ABacteriaAntipyreticInflammatory factorsGastrointestinal inflammation
The invention discloses a phagocytosis-resistant indigo engineering strain, which can sensitively respond to enteritis-related thiosulfate inflammatory factors, timely release a drug indigo to treat gastrointestinal inflammation, and release sfGFP signal molecules to assist in diagnosis and monitoring of diseases, and is very helpful for slowing down disease progression. In addition, through knockout of fhuA and trxA genes related to bacteriophage infection and knockin of an sspB-sspC-sspD-sspE gene cluster, the survival rate of the strain in the intestinal tract can be improved, and the treatment and diagnosis effects of the strain are improved.
Owner:EAST CHINA UNIV OF SCI & TECH

Deepwater net cage culture method for decapterus maruadsi

The invention provides a decapterus maruadsi deepwater net cage culture method, and belongs to the technical field of decapterus maruadsi culture. According to the method, the submersible net cage is adopted, the decapterus maruadsi is located in the optimal growth water layer at the temperature of 20-25 DEG C all the year round according to rising and falling of seasons (surface water temperature), a guide pipe is adopted for fixed-point feed feeding, and the feed coefficient is reduced to 1.25 or below. According to the method, a water temperature-feeding amount-allicin-probiotics coupling model is established, the enteritis incidence rate in the high-temperature period is controlled within 2%, and annual continuous growth of decapterus maruadsi in deep and far sea is achieved.
Owner:FISHERIES RESEARCH INSTITURE OF FUJIAN +1

Heat-resistant bacillus orientalis with phagocytosis activity and application of heat-resistant bacillus orientalis

The invention belongs to the technical field of bioengineering, and relates to bacillus orientalis and application thereof in bacteriostasis and disease prevention, in particular to bacillus orientalis P2-1 and a microbial agent thereof, and application of the bacillus orientalis P2-1 and the microbial agent in inhibition of pathogenic bacteria in water and prevention of river crab diseases. The bacillus subtilis has a good phagocytosis effect on pathogenic bacteria such as pseudomonas aeruginosa, shewanella alga, citrobacter freundii, klebsiella pneumoniae and enterobacter glycosides, and can be used for remarkably removing the pathogenic bacteria such as the pseudomonas aeruginosa, the shewanella alga, the citrobacter freundii, the klebsiella pneumoniae and the enterobacter glycosides in a water body; the pseudomonas disease of the river crabs is effectively prevented and controlled, and a good effect is achieved on simultaneously preventing black gill disease, hepatopancreas necrosis disease, water shriveled disease, enteritis disease, edema disease and trembling disease in the culture and production of the river crabs.
Owner:SHANGHAI OCEAN UNIV +2